透析的终末期肾病患者下肢血运重建:开放手术与腔内治疗结局比较
基于美国肾脏数据系统2005至2011年数据,比较透析的终末期肾病患者下肢开放手术血运重建(OSR)与腔内血运重建(ER)的结局。共纳入20347例,ER占79.7%。调整混杂因素后,OSR与更高的30天死亡率(OR 2.00)和心肌梗死风险(OR 1.38)相关,但30天大截肢风险更低(OR 0.67);长期死亡率OSR略高(HR 1.05),长期截肢无差异。
要点
- 透析的ESRD患者下肢血运重建后死亡和截肢风险高。
- OSR较ER的30天死亡率更高(OR 2.00),心肌梗死风险也更高。
- OSR的30天大截肢风险低于ER(OR 0.67),但长期截肢无差异。
核心结论
- 在透析的ESRD患者中,下肢血运重建后死亡率和截肢率均较高;与ER相比,OSR与更高的死亡率相关,但30天保肢更优,长期结局相似。
研究设计与样本
- 回顾性分析美国肾脏数据系统2005至2011年数据,纳入20347例接受下肢OSR或ER的ESRD透析患者。
- OSR占20.3%,ER占79.7%;间歇性跛行或严重肢体缺血为手术指征,其中ER组80.8%、OSR组88.4%为严重肢体缺血。
主要发现
- 未调整的30天大截肢率ER高于OSR(8.8% vs. 6.4%,p < .001),30天死亡率ER低于OSR(8.0% vs. 10.5%,p < .001)。
- 多因素logistic回归调整医学协变量及指征后,OSR较ER的30天死亡风险增加(OR 2.00,95%CI 1.43-1.79,p < .001),心肌梗死风险增加(OR 1.38,95%CI 1.23-1.54,p < .001),死亡和大截肢复合终点风险增加(OR 1.57,95%CI 1.16-2.12,p = .004),但30天大截肢单独风险降低(OR 0.67,95%CI 0.58-0.77,p < .001)。
- 比例风险模型显示,OSR较ER的长期死亡风险增加(HR 1.05,95%CI 1.00-1.09,p = .037),大截肢风险无差异(HR 0.99,95%CI 0.93-1.05,p = NS)。
临床怎么用
- 对于透析的ESRD合并下肢PAD患者,选择血运重建方式时需权衡OSR的更高短期死亡风险与ER的更高短期大截肢风险。
- OSR可能带来更好的30天保肢效果,但长期保肢获益与ER相似,决策应结合患者个体化风险评估。
局限性
- 本研究为行政数据库的回顾性分析,可能存在编码偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: End stage renal disease (ESRD) patients with peripheral arterial disease (PAD) are at high risk of complications following open surgical revascularisation (OSR). Endovascular revascularisation (ER) is an option, but its role is unclear. This study sought to characterise the outcomes of ER and OSR in ESRD patients treated for claudication or critical limb ischaemia (CLI). METHODS: The United States Renal Data System was used to investigate outcomes after lower extremity ER and OSR from 2005 to 2011. Primary outcomes were mortality, amputation, and peri-procedural myocardial infarction (MI). Kaplan-Meier (K-M) estimates were generated for mortality and amputation, logistic regression models for 30 day predictors, and proportional hazards models for long-term predictors. RESULTS: A total of 20,347 patients underwent OSR and ER (20.3% OSR, 79.7% ER). CLI was the indication in 80.8% of ER and 88.4% of OSR. The unadjusted major amputation rate at 30 days was higher after ER compared with OSR (8.8% vs. 6.4%, p < .001). Conversely, the unadjusted mortality rate at 30 days was lower after ER compared with OSR (8.0% vs. 10.5%, p < .001). Multivariable logistic regression models adjusting for medical covariables and CLI versus claudication status demonstrated increased 30 day mortality risk with OSR compared with ER (OR 2.00, 95% CI 1.43-1.79, p < .001), MI (OR 1.38, 1.23-1.54, p < .001), and the combined endpoint of mortality and major amputation (OR 1.57, 1.16-2.12, p = .004), but lower odds of 30 day major amputation alone (OR 0.67, 0.58-0.77, p < .001). Proportional hazards models demonstrated increased long-term mortality risk with OSR compared with ER (HR 1.05, 1.00-1.09, p = .037), without a difference in major amputation (HR 0.99, 0.93-1.05, p = NS). CONCLUSIONS: In this retrospective analysis of an administrative database, ESRD patients suffer from high mortality and amputation rates following lower extremity revascularisation. Compared with ER, OSR is associated with higher mortality. OSR has better 30 day limb salvage, although long-term outcomes are similar.
引用
- Yuo TH, Wallace JR, Fish L, et al. Editor's Choice - Comparison of Outcomes After Open Surgical and Endovascular Lower Extremity Revascularisation Among End Stage Renal Disease Patients on Dialysis. Eur J Vasc Endovasc Surg. 2018. PMID: 30385187. doi:10.1016/j.ejvs.2018.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。